Publications

• 2020
  • L. Bousset, A. Septier, J. Bunay, A. Voisin, R. Guiton, C. Damon-Soubeyrant, Y. Renaud, A. De Haze, V. Sapin, A. Fogli, A. Rambur, C. De Joussineau, A. Kocer, A. Trousson, J. Henry-Berger, M. Horing, G. Liebisch, S. Matysik, J. Lobaccaro, L. Morel and S. Baron, “Absence of nuclear receptors LXRs impairs immune response to androgen deprivation and leads to prostate neoplasia.”, PLoS biology, vol. 18 (12) , pp. e3000948, 2020.
  • A. Rambur, C. Lours-Calet, C. Beaudoin, J. Bunay, M. Vialat, V. Mirouse, A. Trousson, Y. Renaud, J. Lobaccaro, S. Baron, L. Morel and C. de Joussineau, “Sequential Ras/MAPK and PI3K/AKT/mTOR pathways recruitment drives basal extrusion in the prostate-like gland of Drosophila.”, Nature communications, vol. 11 (1) , pp. 2300, 2020.
• 2019
  • N. Zabaiou, A. Fouache, A. Trousson, J. Bunay-Noboa, G. Marceau, V. Sapin, A. Zellagui, S. Baron, M. Lahouel and J. Lobaccaro, “Ethanolic extract of Algerian propolis decreases androgen receptor transcriptional activity in cultured LNCaP cells.”, The Journal of steroid biochemistry and molecular biology, vol. 189 , pp. 108–115, 2019.
  • O. Celhay, L. Bousset, L. Guy, J. Kemeny, V. Leoni, C. Caccia, A. Trousson, C. Damon-Soubeyrant, A. De Haze, L. Sabourin, C. Godfraind, C. de Joussineau, B. Pereira, L. Morel, JM. Lobaccaro and S. Baron, “Individual Comparison of Cholesterol Metabolism in Normal and Tumour Areas in Radical Prostatectomy Specimens from Patients with Prostate Cancer: Results of the CHOMECAP Study.”, European urology oncology, vol. 2 (2) , pp. 198–206, 2019.
• 2018
  • L. Bousset, A. Rambur, A. Fouache, J. Bunay, L. Morel, J. Lobaccaro, S. Baron, A. Trousson and C. de Joussineau, “New Insights in Prostate Cancer Development and Tumor Therapy: Modulation of Nuclear Receptors and the Specific Role of Liver X Receptors.”, International journal of molecular sciences, vol. 19 (9) , 2018.
• 2017
  • Z. Ouedraogo, A. Fouache, A. Trousson, S. Baron and J. Lobaccaro, “Role of the liver X receptors in skin physiology: Putative pharmacological targets in human diseases.”, Chem. Phys. Lipids, vol. 207 (Pt B) , pp. 59–68, 2017.
  • N. Zabaiou, A. Fouache, A. Trousson, S. Baron, A. Zellagui, M. Lahouel and J. Lobaccaro, “Biological properties of propolis extracts: Something new from an ancient product.”, Chem. Phys. Lipids, vol. 207 (Pt B) , pp. 214–222, 2017.
• 2016
  • S. Maqdasy, A. Trousson, I. Tauveron, D. Volle, S. Baron and J. Lobaccaro, “Once and for all, LXRalpha and LXRbeta are gatekeepers of the endocrine system.”, Molecular aspects of medicine, 2016.
  • M. Whitfield, A. Ouvrier, R. Cadet, C. Damon-Soubeyrand, R. Guiton, L. Janny, A. Kocer, G. Marceau, H. Pons-Rejraji, A. Trousson, J. Drevet and F. Saez, “Liver X Receptors (LXRs) Alpha and Beta Play Distinct Roles in the Mouse Epididymis.”, Biol Reprod, vol. 94 (3) , pp. 55, 2016.
  • JM. Lobaccaro, C. Beaudoin, B. Bayala, S. Baron and A. Trousson, “Lipid Homeostasis and Ligands for Liver X Receptors: Identification and Characterization.”, Meth. Mol. Biol., vol. 1443 , pp. 13–9, 2016.
• 2015
  • O. Celhay, G. Laurent, A. Alioui, A. Trousson, L. Kemeny, B. Pereira, V. Leoni, J. Lobaccaro and S. Baron, “[Not Available].”, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, vol. 25 (13) , pp. 727–8, 2015.
  • S. Maqdasy, F. El Hajjaji, M. Baptissart, E. Viennois, A. Oumeddour, F. Brugnon, A. Trousson, I. Tauveron, D. Volle, J. Lobaccaro and S. Baron, “Identification of the functions of Liver X Receptor beta in Sertoli cells using a targeted expression-rescue model.”, Endocrinology, pp. en20151382, 2015.
  • A. Varin, C. Thomas, M. Ishibashi, L. Menegaut, T. Gautier, A. Trousson, V. Bergas, J. de Barros, M. Narce, JM. Lobaccaro, L. Lagrost and D. Masson, “Liver X Receptor Activation Promotes Polyunsaturated Fatty Acid Synthesis in Macrophages: Relevance in the Context of Atherosclerosis.”, Arteriosclerosis, thrombosis, and vascular biology, 2015.
  • H. De Boussac, S. Maqdasy, A. Trousson, N. Zelcer, D. Volle, JM. Lobaccaro and S. Baron, “Enolase is regulated by Liver X Receptors.”, Steroids, 2015.
• 2014
  • JM. Lobaccaro and A. Trousson, “Environmental estrogen exposure during fetal life: a time bomb for prostate cancer.”, Endocrinology, vol. 155 (3) , pp. 656–8, 2014.
• 2013
  • H. De Boussac, A. Alioui, E. Viennois, J. Dufour, A. Trousson, A. Vega, L. Guy, DH. Volle, JM. Lobaccaro and S. Baron, “Oxysterol receptors and their therapeutic applications in cancer conditions.”, Expert Opin. Ther. Targets, vol. 17 (9) , pp. 1029–38, 2013.
  • J. Hoang, S. Baron, DH. Volle, JM. Lobaccaro and A. Trousson, “Lipids, LXRs and prostate cancer: are HDACs a new link?”, Biochemical pharmacology, vol. 86 (1) , pp. 168–74, 2013.
  • A. Pommier, J. Dufour, G. Alves, E. Viennois, H. De Boussac, A. Trousson, DH. Volle, F. Caira, P. Val, P. Arnaud, JM. Lobaccaro and S. Baron, “Liver x receptors protect from development of prostatic intra-epithelial neoplasia in mice.”, PLoS Genet., vol. 9 (5) , pp. e1003483, 2013.
  • H. de Boussac, A. Pommier, J. Dufour, A. Trousson, F. Caira, DH. Volle, S. Baron and JM. Lobaccaro, “LXR, prostate cancer and cholesterol: the Good, the Bad and the Ugly.”, Am J Cancer Res, vol. 3 (1) , pp. 58–69, 2013.
• 2011
  • M. Tawk, J. Makoukji, M. Belle, C. Fonte, A. Trousson, T. Hawkins, H. Li, S. Ghandour, M. Schumacher and C. Massaad, “Wnt/beta-catenin signaling is an essential and direct driver of myelin gene expression and myelinogenesis.”, J. Neurosci., vol. 31 (10) , pp. 3729–42, 2011.
• 2009
  • A. Trousson, S. Bernard, P. Petit, P. Liere, A. Pianos, K. El Hadri, JM. Lobaccaro, M. Ghandour, M. Raymondjean, M. Schumacher and C. Massaad, “25-hydroxycholesterol provokes oligodendrocyte cell line apoptosis and stimulates the secreted phospholipase A2 type IIA via LXR beta and PXR.”, Journal of neurochemistry, vol. 109 (4) , pp. 945–58, 2009.